CSL Behring commissioned The Economist Intelligence Unit to study rare disease care in the Asia-Pacific region. The results, released in July, showed that far too many patients don’t get the best, evidence-based care. This infographic explores key findings in the white paper.
Learn more about “Suffering in Silence” and how 258 million rare disease patients receive care.
![Too few rare disease patients get best available care in Asia-PAC](https://www.csl.com/-/media/shared/vita/eiu-infographic_final_full_english.png?h=4238&iar=0&w=1600&hash=68D7965BFDFEDE0F52A752ECFD5A1833)